期刊文献+

异丙酚单用与复合芬太尼在隆鼻术中麻醉效果比较 被引量:2

Comparison between propofol alone and combined with fentanyl in anesthesia for nose augmentation
下载PDF
导出
摘要 目的:比较异丙酚单独或复合芬太尼用于无痛隆鼻术中的麻醉效果。方法:就医者40例,随机分配为A组(异丙酚)和B组(异丙酚复合芬太尼),每组各20例。A组静注异丙酚1.5~2mg.kg-1使其入睡后手术开始,术中异丙酚以4~6mg.kg-1.h-1微泵维持。B组先静脉注射芬太尼0.1mg,随后麻醉过程同A组。记录术中体动反应次数、异丙酚用量,记录麻醉前、麻醉后2mi n、5mi n、10mi n、手术结束时的MAP、HR、RR和SPO2,记录麻醉过程中发生的不良反应。结果:B组术中体动反应次数和异丙酚用量都明显少于A组(P<0.01),B组麻醉后2mi n时MAP、HR、RR和SPO2明显下降(P<0.05或P<0.01),但在麻醉后5mi n时都恢复正常。结论:在无痛隆鼻术麻醉中复合芬太尼未明显增加麻醉不良反应,但增强了镇痛效果,能明显减少体动反应,减少异丙酚使用量,降低治疗费用。 Objective To compare the effect of propofol alone with that combined with fentanyl in anesthesia for nose augmentation. Methods 40 patients received nose augmentation were randomized into group A (propofol) and group B (propofol and fentanyl), each group 20 patients. In group A, propofol 1.5-2mg.kg^-1 was administered i.v. before surgery followed with 4-6mg.kg^-1.h^-1 with microinfusion pump. In group B, fentanyl 0.1 mg i.v. before propofol was used and other procedure was the same as group A. Restless movings, doses of propofol and adverse effects during the procedure were recorded. MAP, HR, RR and SPO2 at preanesthesia, 2min, 5min, 10min and immediately after the surgery were recorded too. Results The restless movings and propofol doses were fewer in group B than in group A (P〈0.05). MAP, HR, RR and SPO2 significantly decreased at 2 minute in group B (P〈0.05 or P〈0.01),but resumed to the level of preanesthesia at 5 minute. Conclusion Adverse effects during anesthesia did not significantly increase when propofol combined with fentanyl for nose augmentation. But the efficacy of analgesia was enhanced, thus restless movings, propofol doses and expense of treatment decreased.
出处 《中国美容医学》 CAS 2007年第9期1220-1222,共3页 Chinese Journal of Aesthetic Medicine
关键词 异丙酚 芬太尼 麻醉 隆鼻术 propofol fentanyl anesthesia nose augmentation
  • 相关文献

参考文献6

二级参考文献17

  • 1刘存明,张国楼,王忠云,王灿琴,韩传宝,郝秀芬.咪唑安定辅助区域麻醉合适镇静深度及用量的探讨[J].临床麻醉学杂志,2005,21(1):20-22. 被引量:122
  • 2王玲.异丙酚临床应用的新进展[J].国外医学(麻醉学与复苏分册),1994,15(5):268-270. 被引量:20
  • 3Borgeat A, Oliver HG, Smith W. The nonhypnotic therapeutic applications of propofol[J].Anaesthesiology ,1994,80(3):632.
  • 4Glen JB, Hunter SC. Parmacology of an emulsion formulation of IC135-858[J]. Br J Anaesth, 1984,54:617.
  • 5Cockshott ID.Propofol ('Diprivan')pharmacokinetics and metabolism an overview[J]. Postgrad Med J, 1985,61(3):45.
  • 6Ramsay MAE,Savege TM,Simpson BRJ, et al.Controlled sedation with alphaxolone alphadolone[J].Br J Anaesth, 1980,52:541-545.
  • 7Biswas S,Bhatnagar M,Rhatigan M, et al. Low dose midazolam infusion for oculoplastic surgry under local anesthesia [J].Eye,1999,13:537-540.
  • 8Rudner R,Jalowiecki P,Kawecki P,et al. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl,midazolam,and propofol for outpatient colonoscopy[J]. Gastrointest Endosec,2003,57: 657-663.
  • 9Kostash MA,Johnston R,Bailey RJ,et al. Sedation for colonscopy double-blin comparison of diazepam/meperidine,midszolarm/fentanyl and porpofol/fentanyl combinations[J]. Can J Gastroenterol,1994,8:1.
  • 10ReverJG. Glass PSA,Lubarsly DA.Noubarbyturate intravenous[M]. Churchill Livingstone,2000.228.

共引文献67

同被引文献8

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部